ANTIRIBONUCLEOPROTEIN ANTIBODIES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - COMPARATIVE-STUDY WITH CHILDHOOD-ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS
Cm. Gonzalez et al., ANTIRIBONUCLEOPROTEIN ANTIBODIES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - COMPARATIVE-STUDY WITH CHILDHOOD-ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS, Pediatric AIDS and HIV infection, 7(6), 1996, pp. 401-408
A number of clinical and laboratory features of human immunodeficiency
virus (HIV) infection are found in systemic lupus erythematosus (SLE)
. Objective. To analyze the presence of circulating antibodies to smal
l nuclear ribonucleoproteins (snRNP) in both diseases. Methods. We stu
died sera from 44 HIV-infected children, from 22 patients with childho
od-onset SLE, and from 50 healthy children. Anti-snRNP antibodies were
detected by (ELISA) using recombinant and affinity-purified nuclear a
ntigens, by counterimmunoelectrophoresis (CIE), and by immunoblotting
using extractable nuclear antigens. Results. Anti-snRNP antibodies wer
e detected by ELISA in 30 HIV-infected patients (68.1%) and 19 SLE pat
ients (86.3%). These antibodies were directed against U1-RNP (61.3% an
d 77.2%), Sm (29.5% and 54.5%), 60kD-Ro/SS-A (47.7% and 50%), and La/S
S-B proteins (18.1% and 9%), respectively. None of the HIV-infected ch
ildren and 11 SLE patients (50%) showed anti-snRNP antibodies by CIE.
None of the HIV-infected patients showed anti-70 kD U1-RNP or anti-D-S
m antibodies by immunoblotting. No differences between the two groups
were noted relative to the presence of nonprecipitating anti-snRNP ant
ibodies. No such reactivities were observed among the normal sera test
ed. Conclusions. Nonprecipitating anti-snRNP antibodies in HIV-infecte
d children are as frequent as in childhood-onset SLE. The significance
of these antibodies is not clear at present. Perhaps they are polyrea
ctive and low-affinity antibodies and a mechanism of molecular mimicry
may explain these results; however, we cannot exclude a specific stim
ulation of B-cells by nuclear antigens.